Exchange: NASDAQ Capital Market Sector: Financial Services Industry: Shell Companies
127.33% $22.71
/ 1 aug 2022 @ 00:00
FUNDAMENTALS | |
---|---|
MarketCap: | 559.61 mill |
EPS: | -0.372 |
P/E: | -61.05 |
Earnings Date: | Jul 04, 2022 |
SharesOutstanding: | 24.64 mill |
Avg Daily Volume: | 0 mill |
RATING 2022-07-29 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Strong Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/21 | 2/21 | 3/21 | 4/21 | 1/22 | 2/22 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | n/a | |||||
Asset | n/a | |||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -61.05 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -61.05 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 22.70 - 22.72 ( +/- 0.04%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-02-11 | Glazer Capital, Llc | Sell | 400 000 | Units |
2021-01-29 | Glazer Capital, Llc | Buy | 0 | Common Stock, par value $0.0001 per share |
2021-01-28 | Serafini Tito | Buy | 0 | |
2017-06-28 | Xu Peixin | Buy | 39 375 | Ordinary share, no par value |
2017-06-28 | Xu Peixin | Buy | 39 375 | Rights |
INSIDER POWER |
---|
0.00 |
Last 13 transactions |
Buy: 295 314 | Sell: 943 750 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $22.71 (127.33% ) |
Volume | 0.586 mill |
Avg. Vol. | 0 mill |
% of Avg. Vol | 0 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.